Search Results

You are looking at 131 - 140 of 653 items for :

  • "surveillance" x
Clear All
Full access

Peter A. Ubel

surveillance, surgery, and radiotherapy. Each option has pros and cons, which are weighed differently by different patients. In brief, Dr. Ubel noted, the conversation with the patient could go something like, “You can have a surveillance strategy that

Full access

Gold Standard for Prostate Cancer Care Kawachi Mark H. MD 08 2007 5 5 7 7 689 689 692 692 0050689 10.6004/jnccn.2007.0059 Point: Active Surveillance for Favorable Risk Prostate Cancer Klotz Laurence MD, FRCSC 08 2007 5 5 7 7 693

Full access

footnote “k” was added: “Ta verrucous carcinoma is by definition a well-differentiated tumor and would require surveillance alone of inguinal lymph nodes.” Footnote “n” was added: “A modified/superficial inguinal dissection with intraoperative frozen

Full access

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony Victor D'Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben, Sylvia Richey, Mack Roach III, Stan Rosenfeld, Edward Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan Tward, Dorothy A. Shead and Deborah A. Freedman-Cass

figures. Risk Stratification Management approaches for locoregional prostate cancer include surgery, radiotherapy, active surveillance (actively monitoring disease, with curative-intent intervention if cancer progresses), observation (monitoring

Full access

Benjamin L. Franc, Timothy P. Copeland, Robert Thombley, Miran Park, Ben Marafino, Mitzi L. Dean, W. John Boscardin, Hope S. Rugo, David Seidenwurm, Bhupinder Sharma, Stephen R. Johnston and R. Adams Dudley

breast cancer diagnosed by age 50 years, receive dedicated breast MRI annually. 2 ASCO and NCCN have issued guidelines stating that, after initial treatment, surveillance for recurrence in patients with stage I–III breast cancer should include periodic

Full access

Heather Hampel

their relatives to undergo genetic counseling and testing to learn if they too are at increased risk for cancer and could benefit from intensive cancer surveillance. The costs of screening can be offset by the benefits of cancer prevention in the patient

Full access

Mary Ann Morgan and Crystal S. Denlinger

-management; (2) surveillance for cancer spread, recurrence, or second cancers, along with monitoring for late effects, including psychological consequences; (3) interventions for these effects; and (4) coordination between the oncology providers and PCPs. 5

Full access

Christina A. Minami and Karl Y. Bilimoria

present, with information from more than 1,500 CoC-accredited hospitals throughout the United States and Puerto Rico. The NCDB is a facility-based clinical surveillance resource that is also meant to be used in quality improvement (QI), allowing hospitals

Full access

Randall W. Burt, James S. Barthel, Kelli Bullard Dunn, Donald S. David, Ernesto Drelichman, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley R. Hamilton, Mohammad K. Ismail, Kory Jasperson, Audrey J. Lazenby, Patrick M. Lynch, Edward W. Martin Jr., Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe Shike, Gideon Steinbach, Jonathan P. Terdiman and David Weinberg

reduction persists after colonoscopy. They compared incidence of CRC among patients in the surveillance cohort with that in the general population. A negative colonoscopy was associated with a standardized incidence ratio of 0.28 (95% CI, 0.09–0.65) at 10

Full access

of capecitabine + oxaliplatin was added as an option in adjuvant therapy with a category 2A designation. Footnote “j” was clarified by adding “exclusive of those cancers that are MSI-H” to grade 3-4. Surveillance Chest